

share
Panobacumab CAS NO 885053-97-4
Unit Price:
CAS No.:885053-97-4
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Panobacumab is a human monoclonal antibody specifically developed for therapeutic intervention against severe bacterial infections. This product is critical for addressing the growing global challenge of antibiotic-resistant pathogens, offering a targeted immunological approach. It is primarily utilized by pharmaceutical manufacturers, biotechnology research institutions, and clinical development organizations engaged in advanced infectious disease therapeutics.
Application
- Therapeutic Development: Primary active pharmaceutical ingredient (API) for novel anti-infective biologics targeting Pseudomonas aeruginosa.
- Clinical Research: Critical reagent in preclinical and clinical studies investigating immunotherapeutic strategies for hospital-acquired infections.
- Biodefense: Potential component in strategic stockpiles for treating infections caused by multidrug-resistant (MDR) bacterial agents.
- Combinatorial Therapy: Used in research to evaluate synergistic effects with conventional antibiotics to enhance efficacy and overcome resistance.
- Diagnostic Tool Development: Serves as a reference standard in the development of immunoassays for pathogen detection and serotyping.
Basic Information
| Product Name | Panobacumab |
| CAS No. | 885053-97-4 |
| Molecular Formula | Data on file |
| Molecular Weight | Approx. 150 kDa (Contact for details) |
| Synonyms | Anti-Pseudomonas aeruginosa Human Monoclonal Antibody; KBPA-101; Aerumab; Monoclonal Antibody KBPA101; Anti-LPS O11 Human IgG1κ; Human Anti-P. aeruginosa O11 IgG1 Monoclonal Antibody; Panobacumab (INN); UNII-6QZ1HYV6A8 |
| EINECS | Contact for details |
Quality Control
Our Panobacumab is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical characterization to ensure identity, purity, potency, and safety, meeting the stringent requirements for biopharmaceutical development. Certificates of Analysis (COA) detailing specifications such as purity (by SEC-HPLC), endotoxin levels, sterility, and binding activity are provided.
Storage
Preserve in a tightly closed container, protected from light. For long-term stability, store at -20°C or below. Avoid repeated freeze-thaw cycles. The product is hygroscopic (moisture-sensitive); ensure containers are sealed under controlled, dry conditions.
Specification
| Item | Specification |
|---|---|
| Appearance | Clear to slightly opalescent, colorless to pale yellow solution |
| Identification (HPLC/ELISA) | Conforms to reference standard |
| Purity (SEC-HPLC) | ≥ 95.0% (Monomer) |
| Protein Concentration | As per COA (typically 1-10 mg/mL) |
| Potency (Binding Assay) | ≥ 90% relative activity |
| Endotoxin | < 1.0 EU/mg |
| Sterility | Sterile (or meets applicable pharmacopeial limits) |
| pH | 6.0 - 7.5 |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Pembrolizumab CAS NO 1374853-91-4


Tuvirumab CAS NO 138660-97-6


Biciromab CAS NO 138783-13-8


Muromonab-Cd3 CAS NO 140608-64-6


Anti-Stromelysin-2 CAS NO 140610-48-6


Gendevit CAS NO 141910-80-7


Edrecolomab CAS NO 156586-89-9


Felvizumab CAS NO 167747-20-8


Faralimomab CAS NO 167816-91-3


Rovelizumab [Usan:Inn] CAS NO 197099-66-4


Teprotumumab CAS NO 1036734-93-6


Monalizumab CAS NO 1228763-95-8


Anifrolumab CAS NO 1326232-46-5


Anti-Br140-Like Protein Antibody Produced In Rabbit CAS NO 1597439-92-3


Eptinezumab CAS NO 1644539-04-7


Rhumab Cd 168 CAS NO 211323-03-4


Ociperlimab CAS NO 2342597-93-5


Tadocizumab CAS NO 339086-80-5


Galiximab CAS NO 357613-77-5


Tocilizumab CAS NO 375823-41-9
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






